- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2018
- Public Summary Document (PSD) November 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2018 PBAC Meeting - Word
Nivolumab and ipilimumab – November 2018
Nivolumab And Ipilimumab: nivolumab: Injection concentrate for I.V. infusion 40 mg in 4 mL, Injectio
Last updated
1 March 2019